Leukotriene receptor antagonists in the treatment of asthma.
- 1 March 2001
- journal article
- review article
- Published by Wiley in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
- Vol. 21 (3) , 34S-37S
- https://doi.org/10.1592/phco.21.4.34s.34262
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Montelukast, a leukotriene receptor antagonist, reduces the concentration of leukotrienes in the respiratory tract of children with persistent asthmaJournal of Allergy and Clinical Immunology, 1999
- Montelukast Added to Inhaled Beclomethasone in Treatment of AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trialEuropean Respiratory Journal, 1999
- Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic AsthmaAnnals of Internal Medicine, 1999
- Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic AsthmaA Multicenter, Randomized, Double-blind TrialArchives of internal medicine (1960), 1998
- Montelukast for Chronic Asthma in 6- to 14-Year-Old ChildrenJAMA, 1998
- Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant AsthmaticsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Induction of nitric oxide synthase activity in pulmonary arteries from normoxic and chronically hypoxic ratsEuropean Respiratory Journal, 1997
- The Role of Leukotrienes in InflammationAnnals of Internal Medicine, 1994
- Leukotrienes and Airway ResponsesAmerican Review of Respiratory Disease, 1987